BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$56.10
+1.01%
Mkt Cap $10.93B
Analyst Ratings
Buy
17
Hold
5
Sell
0
Price Target (59 analysts)
$86.60
Range $60.00 – $105.00
Implied Upside
+54.4%
Consensus $86.60 vs current $56.10
NASDAQ·Healthcare·Biotechnology
$56.10
+1.01%
Mkt Cap $10.93B
Buy
17
Hold
5
Sell
0
Price Target (59 analysts)
$86.60
Range $60.00 – $105.00
+54.4%
Consensus $86.60 vs current $56.10